Short-Term and Highly Intensive Early Intervention FIAS: Two-Year Outcome Results and Factors of Influence.

Background: Comprehensive behaviorally or developmentally based early intervention programs have been shown to be effective in improving cognitive, social communicative, and adaptive skills of children with autism spectrum disorder (ASD). Besides the definition of relevant outcome predictors, the question of whether early intensive intervention positively changes core autism symptoms in children, as well as their long-term outcome, is an important issue for current research. The primary objective of the current study was to examine whether symptomatic and behavioral changes in children up to 4.

Become Related: FIAS, an Intensive Early Intervention for Young Children with Autism Spectrum Disorders.

Background: In autism spectrum disorders (ASDs), impairments in fundamental social abilities and a lack of interest in social stimuli become apparent early in life. These impairments are thought to negatively affect further brain and behavioural development. Early intensive interventions can help to attenuate social-development and other risk factors and, thus, to ameliorate the deficits associated with ASDs.

Highly strained graphene samples of varying thickness and comparison of their behaviour.

Mechanically straining graphene opens the possibility to exploit new properties linked to the stressed lattice of this two-dimensional material. In particular, theoretical analyses have forecast that straining graphene by more than 10% is a requirement for many novel applications that have not yet been experimentally demonstrated. Recently, we reported having achieved 12.

Controlled, reversible, and nondestructive generation of uniaxial extreme strains (>10%) in graphene.

Theoretical calculations have predicted that extreme strains (>10%) in graphene would result in novel applications. However, up to now the highest reported strain reached ∼1.3%.

Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme/prodrug therapy.

Background: The cytosine deaminase/5-fluorocytosine (CD/5-FC), strategy for cancer gene therapy shows considerable promise in experimental models but, because CD is a cytosolic enzyme, intracellular production of 5-fluorouracil (5-FU) causes the demise of the transduced cells before cytotoxic concentrations of' 5-FU can be achieved within the extracellular milieu.

Materials And Methods: A soluble secreted form of CD was constructed and evaluated compared to intracellular CD in vitro and in vivo.

Results: The secreted form of CD temporarily spared transduced cells and enhanced accumulation of extracellular 5-FU.